The Case for Immunotherapy Trials That Reflect the Real World of Metastatic Melanoma
The problem of low representation of racial minorities is especially urgent during the era of immunotherapy trials.
Skin Cancer
SKIN CANCER ADVISOR
FEATURED CONTENT
-
-
Knowing the Appropriateness of Running Noninferiority Trials in Oncology
Researches took a critical look at noninferiority trials and determined that when a new intervention is “not worse,” the possibility exists that it is not better, either. -
Tapping Into the Therapeutic Expertise of High-Volume Cancer Centers
Researchers examine how patient outcomes could be affected if patients were to receive systemic drug treatment at dedicated cancer centers versus at community health systems. -
Personalized Cancer Vaccine NEO-PV-01 Shows Promise in 3 Types of Advanced Cancer
Early results from a clinical trial of personalized cancer vaccine NEO-PV-01 in 3 types of advanced cancer have shown promise and no significant toxicity issues. -
New Research on Anti–PD-1 Drugs Helps Fill Gaps in Knowledge on Immunotherapies in Melanoma
Oncologists lacking long-term data now have more information on relapse rates and the role of obesity in treatment success.
VIDEO SERIES
Recent Advances in Melanoma Therapy
Targeted Treatments and Immunotherapies for Melanoma
Tailoring Treatments in Melanoma
Drug Resistance in Melanoma
Affordability of Melanoma Care
Melanoma: Treatment-induced Toxicity
Immunotherapy: A Decade of Improvements in Melanoma
Should Patients With Melanoma Receive Targeted Therapy or Immunotherapy First?
Melanoma: Checkpoints in the Pipeline
Targeting Therapy for Melanoma Subtypes
Melanoma: Targetable Genes in the Pipeline
Clinical Trials in Melanoma
SKIN CANCER NEWS
2001 to 2016 Saw Large Increase in Mohs Surgery for Melanoma
TKI Combination vs Monotherapy for Advanced Melanoma and the Risk for CV Adverse Events
Rozlytrek, a Tumor Agnostic Therapy, Receives FDA Approval
Bempegaldesleukin Combo Regimen Gets Breakthrough Status for Untreated Advanced Melanoma
Dietary Vitamin A Intake Tied to Reduced Risk for Squamous Cell Carcinoma
Want to read more?
Please login or register first to view this content.
Next post in Skin Cancer
